Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients

por Carmona-Fernandes, Diana, Santos, Maria José, Perpétuo, Inês Pedro, Fonseca, João Eurico, Canhão, Helena
Publicado 2011

Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheum...

por Perpétuo, Inês Pedro, Caetano-Lopes, Joana, Rodrigues, Ana Maria, Campanilho-Marques, Raquel, Ponte, Cristina, Canhão, Helena, Ainola, Mari, Fonseca, João Eurico
Publicado 2017